Skip to main content

Peptide injectors warned not to share needles or risk infection

 

A rapid rise in injectable peptides use for muscle growth, weight loss and fitness has prompted health organisations Hepatitis Australia and the Australasian Society for Infectious Diseases to urge Australians to use sterile injecting equipment to reduce the risk of serious infections.

Peptides are short chains of amino acids that influence processes including growth, metabolism and tissue repair. While some are approved medicines, unapproved peptides are increasingly being promoted through social media for bodybuilding, faster recovery, weight loss and anti-ageing.

National data from the Kirby Institute reveals a sharp rise in the injecting of performance and image-enhancing substances, including steroids, peptides and growth hormones, with 14 per cent of people who attended participating needle and syringe programs reporting their use in 2025, up from just 9 per cent in 2022.

Needle and syringe services across Australia are also reporting significantly increased demand for injecting equipment from people using peptides., particularly those involved in fitness and bodybuilding.

Hepatitis Australia CEO Lucy Clynes said anyone injecting peptides needed to understand the risks and always use sterile equipment.

“To protect their health, it’s critical that people who are injecting peptides or other substances fully understand the serious potential health risks involved. Needles, syringes and other injecting equipment must never be shared or reused.

“Sharing injecting equipment can transmit blood-borne viruses including hepatitis B and hepatitis C.

“Using new sterile equipment every time is one of the most important steps people can take to protect themselves. Sterile needles and syringes can be purchased from most pharmacies.

“With peptide use increasing, particularly through fitness communities and social media, we want people to understand how to reduce their risks.”

Australasian Society for Infectious Diseases CEO Dr Irene Kourtis warned that products purchased online may not meet appropriate safety standards and that people injecting these products could risk serious bacterial infections including life-threatening sepsis.

“Using clean injecting equipment reduces but does not eliminate these risks. Sharing injection equipment increases the risk of bacterial infections as well as blood-borne viruses.”

Ms Clynes said the growing popularity of peptides required a practical, non-judgemental public health response.

“People will make their own decisions about what they put into their bodies. Our priority is making sure they have accurate, accessible information and understand how to protect their health.

“If you are injecting, use new sterile equipment every time, never share injecting equipment and dispose of used needles safely.”

People with questions about hepatitis B or hepatitis C can contact HepLink for free, confidential information and support on 1800 437 222 or visit heplink.au.


Media contact: Darren Rodrigo – 0414 783 405

About Hepatitis Australia
Hepatitis Australia is the national peak community organisation working to eliminate hepatitis B and hepatitis C in Australia. It represents eight state and territory community hepatitis organisations and advocates for the rights, health and dignity of people affected by viral hepatitis.

About the Australasian Society for Infectious Diseases (ASID)
ASID is the peak professional body for infectious diseases and clinical microbiology in Australasia. Our members include infectious diseases physicians, clinical microbiologists, scientists, infection control practitioners, public health physicians, sexual health physicians, veterinarians and others in the field of infectious diseases. Together, we improve the quality of life for everyone, through advancing the prevention and treatment of infectious diseases in Australasian and global communities. Visit asid.net.au for more information.